Latest by Myles Helfand
The U.S. Senate publicly unveiled its version of the American Health Care Act on June 22. Many HIV advocacy organizations, health care groups and community leaders have expressed staunch opposition.
This grassroots effort honors people who have been living with HIV for more than 10 years, and seeks to combat stigma and discrimination by educating the public about what it means to live -- and grow older -- with HIV today.
The Trump administration released the first detailed version of its proposed federal budget on May 23. Leading organizations within the HIV community were quick to condemn it.
The first few months after starting HIV treatment are pivotal in determining whether your first regimen will be successful. Yet, if you are brand new to HIV treatment, how can you tell what success is?
Missed a dose? Pondering a treatment break? Worried about HIV medication access while traveling? Top HIV doctors answer your questions in our "Ask the Experts" forums.
The "viral divide" is shrinking thanks to recent advances in HIV prevention, journalist and activist Mathew K. Rodriguez contends. However, a great deal of healing still needs to take place, he said in a wide-ranging Facebook Live interview.
HIV expert Joel Gallant, M.D., M.P.H., recently tackled the question: "How high is the resistance risk if PrEP is inadvertently started during an acute infection?"
Adherence imperfection is one of the more common concerns we hear about from people taking once-daily HIV treatment regimens. They want to know: What's the penalty of a missed or late HIV medication dose?
In areas with easy access to HIV medications, people have a wealth of regimens to choose from that work well and are unlikely to cause serious side effects. In fact, sometimes, it can feel like there are too many choices.